Cic edizioni internazionali
Functional Neurology

Effect of zolpidem in chronic disorders of consciousness: a prospective open-label study

Original Article, 259 - 264
doi: 10.11138/FNeur/2013.28.4.259
Tag this article
Abstract
Enhanced HTML Full text PDF
Zolpidem has been reported as an “awakening drug” in some patients with disorders of consciousness (DOC).
We here present the results of a prospective openlabel study in chronic DOC patients. Sixty patients (35±15 years; 18 females; mean time since insult ± SD: 4±5.5 years; 31 with traumatic etiology) with a diagnosis of vegetative state/unresponsive wakefulness syndrome (n=28) or minimally conscious state (n=32) were behaviorally assessed using the Coma Recovery Scale-Revised (CRS-R) before and one hour after administration of 10 mg of zolpidem. At the group level, the diagnosis did not change after intake of zolpidem (p=0.10) and CRS-R total scores decreased (p=0.01). Twelve patients (20%) showed improved behaviors and/or CRS-R total scores after zolpidem administration but in only one patient was the diagnosis after zolpidem intake found to show a significant improvement (functional object use), which suggested a change of diagnosis. However, in this patient, a double-blind placebo-controlled trial was performed in order to better specify the effects of zolpidem, but the patient, on this trial, failed to show any clinical improvements.
The present open-label study therefore failed to show any clinically significant improvement (i.e., change of Effect of zolpidem in chronic disorders of consciousness: a prospective open-label study diagnosis) in any of the 60 studied chronic DOC patients

Vol. XXXIII (No. 3) 2018 July/September

  1. Errata corrige Functional Neurology 2018;33:2 Article: Epidemiological and clinical characteristics of 492 patients in a vegetative state in 29 Italian rehabilitation units. What about outcome?
  2. Chronic stroke: an oxymoron or a challenge for rehabilitation?
    Baricich A., Carda S.
    doi: 10.11138/FNeur/2018.33.3.123
  3. Effects of a nutraceutical combination in patients with chronic lumbosacral radicular pain
    Geroin C., Tamburin S., Pagano G., Gandolfi M., Tinazzi M.
    doi: 10.11138/FNeur/2018.33.3.125
  4. Effects on balance skills and patient compliance of biofeedback training with inertial measurement units and exergaming in subacute stroke: a pilot randomized controlled trial
    Lupo A., Cinnera A.M., Pucello A., Iosa M., Coiro P., Personeni S., Gimigliano F., Iolascon G., Paolucci S., Morone G.
    doi: 10.11138/FNeur/2018.33.3.131
  5. The required coefficient of friction in Parkinson’s disease: people with freezing of gait
    Rozin Kleiner A.F., Cubillos D.M., Pinto C., Salazar A.P., Marchese R.R., Barros R.M.L., Galli M., Pagnussat A.S.
    doi: 10.11138/FNeur/2018.33.3.137
  6. Non-pharmacological interventions for agitation/aggressive behaviour in patients with dementia: a randomized controlled crossover trial
    Dimitriou T.-D., Verykouki E., Papatriantafyllou J., Konsta A., Kazis D., Tsolaki M.
    doi: 10.11138/FNeur/2018.33.3.143
  7. Improved antioxidant defense in the ventral tegmental area increases pain tolerance in male rats
    Famitafreshi H., Karimian M.
    doi: 10.11138/FNeur/2018.33.3.149
  8. Neurite orientation dispersion and density imaging can detect presymptomatic axonal degeneration in the spinal cord of ALS mice
    Gatto R.G., Mustafi S.M., Amin M.Y., Mareci T.H., Wu Y.-C., Magin R.L.
    doi: 10.11138/FNeur/2018.33.3.155
  9. An acute neurological complication of Crohn’s disease
    Battista F., Tinella E., Colosimo C.
    doi: 10.11138/FNeur/2018.33.3.165
  10. Shaping a pain-free future for cluster headache patients. The Declaration of Paris
    Rossi P., Bruce S., De Pascual M.A., Muller H., Tyminski E.K., De La Torre E.R.
    doi: 10.11138/FNeur/2018.33.3.167
Last Viewed articles: la lista degli ultimi x visitati.
  1. Effect of zolpidem in chronic disorders of consciousness: a prospective open-label study
    Thonnard M., Gosseries O., Demertzi A., Lugo Z., Vanhaudenhuyse A., Bruno M.A., Chatelle C., Thibaut A., Charland-Verville V., Habbal D., Schnakers C., Laureys S.
    doi: 10.11138/FNeur/2013.28.4.259
credits